ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nephrology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

34,265Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 749

$3.63M Total Retail Price of All Prescriptions

Rank: 2 out of 749

966 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
89% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

12% of this provider’s 966 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

3% of this provider’s 31,421 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

53% of this provider’s prescriptions were for brand-name drugs, compared to an average of 31%.

Prescription Price

$106 was the average price of a prescription from this provider, compared to $116 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
AMLODIPINE BESYLATE 1,605 1,476 1 1
CELEBREX 994 940 2 54
METFORMIN HCL 873 808 3 22
ATORVASTATIN CALCIUM 847 809 4 18
LOVAZA 823 774 5 51
NEXIUM 816 762 6 34
SIMVASTATIN 762 682 7 5
OMEPRAZOLE 659 587 8 6
LIDODERM 620 578 9 57
DIOVAN 586 538 10 14
JANUVIA 564 522 11 33
CARVEDILOL 556 505 12 11
ATENOLOL 544 467 13 20
FUROSEMIDE 511 443 14 2
TAMSULOSIN HCL 505 497 15 29
ALLOPURINOL 503 495 16 10
ALENDRONATE SODIUM 497 483 17 40
JANUMET 494 481 18 100
EXFORGE 469 449 10 19 90
ZOLPIDEM TARTRATE 439 422 20 24
AVODART 434 433 21 73
DIOVAN HCT 433 428 22 68
CREON 407 367 23 97
CLOPIDOGREL 405 392 24 42
PLAVIX 404 400 25 56
ACTOS 384 352 26 70
DOXAZOSIN MESYLATE 380 372 27 38
METOPROLOL SUCCINATE 366 333 28 26
AMOXICILLIN 360 318 29 114
LIPITOR 317 286 30 71
DONEPEZIL HCL 315 315 31 55
LEVOTHYROXINE SODIUM 295 247 32 13
DEXILANT 275 253 33 75
LOVASTATIN 260 252 34 52
PEN NEEDLE 250 241 35 101
LANTUS 248 229 36 36
BYSTOLIC 248 228 36 64
GLIMEPIRIDE 244 240 38 61
LYRICA 243 203 39 111
MELOXICAM 242 212 40 78
TRIAMCINOLONE ACETONIDE 239 205 41 85
LOSARTAN POTASSIUM 233 204 42 9
CALCIUM ACETATE 231 177 43 16
ACTONEL 229 221 44 125
NAMENDA 218 218 45 60
MEGESTROL ACETATE 209 204 R 46 69
ZENPEP 208 190 47 157
GLIPIZIDE 207 184 48 32
PROCRIT 200 195 49 66
INSULIN SYRINGE 191 166 50 41
GABAPENTIN 187 145 51 25
LANTUS SOLOSTAR 185 175 52 110
CRESTOR 185 184 52 43
SINGLE USE SWAB 180 163 54 200
AMLODIPINE BESYLATE-BENAZEPRIL 180 171 54 135
CALCITRIOL 171 151 56 17
VOLTAREN 169 137 57 105
BENICAR 166 154 58 87
GLYBURIDE-METFORMIN HCL 163 149 R 59 109
CIPROFLOXACIN HCL 157 135 60 84
ULORIC 147 127 61 72
ONGLYZA 145 125 62 179
RENVELA 145 70 62 3
SPIRONOLACTONE 142 142 64 44
ISOSORBIDE MONONITRATE ER 139 139 65 45
BONIVA 135 135 66 231
ACETAMINOPHEN-CODEINE 133 117 S3 67 79
LISINOPRIL 131 87 68 4
BENAZEPRIL HCL 131 98 68 23
GLYBURIDE 129 111 R 70 103
HYDROCODONE-ACETAMINOPHEN 127 71 S3 71 12
AZOR 125 124 72 158
SINGULAIR 125 122 72 99
FORTEO 123 123 74 245
PREDNISONE 121 103 75 28
EVISTA 117 117 76 123
PANTOPRAZOLE SODIUM 114 111 77 30
RANITIDINE HCL 113 109 78 83
PIOGLITAZONE HCL 109 97 R 79 185
METOPROLOL TARTRATE 106 96 80 7
GEMFIBROZIL 105 102 81 129
LANSOPRAZOLE 103 95 82 207
BENICAR HCT 103 103 82 141
FLECTOR 100 80 84 196
SUCRALFATE 96 71 85 264
SERTRALINE HCL 95 83 86 86
IBANDRONATE SODIUM 94 94 87 218
PREMARIN 93 82 R 88 182
AZITHROMYCIN 91 86 89 65
DEXTROSE WITH SODIUM CHLORIDE 88 87 90 337
LACTULOSE 87 81 91 120
SULFAMETHOXAZOLE-TRIMETHOPRIM 87 68 91 67
METOCLOPRAMIDE HCL 85 72 93 74
PREMPRO 84 81 R 94 237
PRAVASTATIN SODIUM 79 79 95 49
POTASSIUM CHLORIDE 79 76 95 37
ECONAZOLE NITRATE 78 64 97 222
LABETALOL HCL 76 76 98 45
FLUTICASONE PROPIONATE 75 62 99 88
PROLIA 74 72 100 346
FINASTERIDE 74 74 100 131
VESICARE 72 70 102 134
ZOSTAVAX 70 63 103 269
AMITRIPTYLINE HCL 69 48 R 104 168
CLONIDINE HCL 68 53 105 15
MONTELUKAST SODIUM 67 64 106 181
NYSTATIN 66 66 107 176
LOSARTAN-HYDROCHLOROTHIAZIDE 66 65 107 93
HYDROCHLOROTHIAZIDE 66 61 107 27
ACIPHEX 66 63 107 156
AMITIZA 66 66 107 152
ACYCLOVIR 66 55 107 282
COLCRYS 65 56 113 107
AMIODARONE HCL 65 65 113 113
ZETIA 64 39 115 80
TERBINAFINE HCL 64 57 115 363
MICARDIS 64 64 115 212
VICTOZA 3-PAK 61 57 118 230
DICYCLOMINE HCL 57 50 119 255
NIFEDIPINE ER 56 55 120 21
NATEGLINIDE 55 55 121 153
AMOX TR-POTASSIUM CLAVULANATE 55 44 121 192
SENSIPAR 54 34 123 8
WARFARIN SODIUM 52 44 124 31
MICARDIS HCT 52 52 124 221
NYSTATIN-TRIAMCINOLONE 52 49 124 395
DIGOXIN 51 43 127 95
TRIAMTERENE-HCTZ 51 41 127 77
ALCOHOL SWABS 50 50 129 308
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 1, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.